Benefits

• CTSA-funded sites known for cutting edge, performance driven research
• Access to multidisciplinary investigators and study teams
• Good Clinical Practice (GCP)-trained personnel at each performance site
• Established Standard Operating Procedures for quality assurance
• Consistent and effective communication among MARCH leadership and study teams
• Mission consistent with national research goals of regionalization and collaboration
• All sites are accredited by the Association for the Accreditation of Human Research Protections Program (AAHRPP)

[/unordered_list]

• Implement multisite research protocols more quickly and cost-effectively
• Effective administration and coordination mechanisms through a centralized model
• Dedicated leadership and study personnel at each site to enhance communication, continuity, and to assist with coordination
• Standardized data management across sites via clinical trial management system software
• Streamlined regulatory approval process providing a single Institutional Review Board (IRB) of record
• Simplified fiscal management: one contract, one budget, one contact
• Access to larger, more diverse populations leading to increased generalizability

[/unordered_list]

• Recruitment across multiple Midwest sites optimizing accrual success, particularly in studies of rare disease states or those that require an inordinately large sample size
• Geographic reach of ethnic and socioeconomic representation across the  Midwest enabling study of the differences in the causes, occurrence, and characteristics of diseases across populations
• Collective power of large and diverse subject populations from academic institutions across multiple states facilitating rapid enrollment
• Access to greater than 22 million residents across member sites

[/unordered_list]

• Obtain skills related to interdisciplinary, team-based science
• Build relationships and organizational alliances

[/unordered_list]